These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 196132)
21. An assessment of hyperlipidemia (hyperlipoproteinemia) typing in the diagnosis and management of atherosclerosis. Kuo PT Cardiovasc Clin; 1977; 8(1):33-9. PubMed ID: 191193 [No Abstract] [Full Text] [Related]
22. Ischemic heart disease and hyperlipidemia. Wada M; Wada K; Mise J Jpn Circ J; 1975 Mar; 39(3):325-30. PubMed ID: 163934 [TBL] [Abstract][Full Text] [Related]
23. [Hyperlipidemia in the elderly]. Kawano M Nihon Rinsho; 2002 May; 60(5):1017-23. PubMed ID: 12029980 [TBL] [Abstract][Full Text] [Related]
24. [Plasma glycosaminoglycans in patients with coronary disease and hyperlipidemia]. Giannini SD; Strunz CM; Forti N; Credidio Rde A; Diament J; Dereviacki BE; de Góis JM; de Serro-Azul LG Arq Bras Cardiol; 1986 May; 46(5):307-10. PubMed ID: 3471185 [No Abstract] [Full Text] [Related]
25. [Is combined statin and fibrate therapy indicated in the management of mixed hyperlipidemia?]. Luc G Presse Med; 1998 Apr; 27(15):720-2. PubMed ID: 9767913 [TBL] [Abstract][Full Text] [Related]
27. Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia. Lewis JE Angiology; 1982 Sep; 33(9):603-12. PubMed ID: 6957156 [TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of tibric acid (CP 18,524) a new hypolipidemic agent. Sirtori CR; Zoppi S; Quarisa B; Agradi E Pharmacol Res Commun; 1974 Oct; 6(5):445-56. PubMed ID: 4617230 [No Abstract] [Full Text] [Related]
30. [Gemfibrozil in the treatment of lipid metabolism disorders]. Vartanova OA; Aleksandrovskaia TN; Shaldaeva VV Klin Med (Mosk); 1994; 72(1):37-41. PubMed ID: 8196321 [TBL] [Abstract][Full Text] [Related]
31. The prevalence of hyperlipoproteinaemia in vascular disease. Lawrie TD; Lorimer AR; Ballantyne D; Jubb JS; Morgan HG Postgrad Med J; 1975; 51(8):suppl 7-15. PubMed ID: 215984 [TBL] [Abstract][Full Text] [Related]
32. [Therapy of primary hyperlipoproteinemia types IIa, IIb and IV using beta pyridylcarbinol Study on three phases under ambulatory conditions]. Klemens UH; von Löwis P Dtsch Med Wochenschr; 1973 Jun; 98(24):1197-202. PubMed ID: 4350685 [No Abstract] [Full Text] [Related]
33. Effects of CH 13.437 in different types of hyperlipidemia. Harvengt C Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:298+. PubMed ID: 4559547 [No Abstract] [Full Text] [Related]
34. [Study of hypolipemic effect of atheroid in ischemic heart disease associated with various types of hyperlipoproteinemia]. Zakharov VN Sov Med; 1978 Jan; (1):147-8. PubMed ID: 76342 [No Abstract] [Full Text] [Related]
35. [New approaches to the evaluation of the cholesterol content of plasma lipoprotein fractions in normo- and hyperlipoproteinemias]. Suchkova SN; Titov VN; Kurchatova SA; Zadoia AA; Shal'nov AI Kardiologiia; 1978 Jun; 18(6):29-36. PubMed ID: 209240 [TBL] [Abstract][Full Text] [Related]
36. [Effect of youjiangzhi capsule on senile hyperlipidemia]. Zhou WQ; Gao P Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Jul; 13(7):428-9, 390. PubMed ID: 8251730 [TBL] [Abstract][Full Text] [Related]
37. [Efficacy and safety of simvastatin in the treatment of hyperlipidemia in uremic patients undergoing hemodialysis treatment]. Fiorini F; Patrone E; Ardu F; Castelluccio A Minerva Urol Nefrol; 1992; 44(2):165-8. PubMed ID: 1411867 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of fenofibrate or gemfibrozil on serum lipid profiles in Chinese patients with type IIb hyperlipidemia: a single-blind, randomized, and cross-over study. Jen SL; Chen JW; Lee WL; Wang SP Zhonghua Yi Xue Za Zhi (Taipei); 1997 Apr; 59(4):217-24. PubMed ID: 9216117 [TBL] [Abstract][Full Text] [Related]
39. [Typing of hyperlipoproteinemia in patients with coronary atherosclerosis]. Gorbachev VV; Vecherskiĭ GA; Baranov LG Kardiologiia; 1974 Nov; 14(11):113-4. PubMed ID: 4372441 [No Abstract] [Full Text] [Related]